BSN Capital Partners’s Amphenol APH Stock Holding History

BSN Capital Partners’s Portfolio APH Stock Details APH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-119,458	Closed	-$8.33M	–	13
2024 Q3	$8.33M	Buy	+119,458	New	+$7.74M	1.62%	29

Other funds holding APH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BSN Capital Partners's APH Position: Q4 2024 in Review

BSN Capital Partners sold out of Amphenol (APH) in Q4 2024, closing a stake of 119,458 shares — an estimated $8.33M sold.

BSN Capital Partners first reported a position in APH in Q3 2024 and held it in 1 quarter. The position peaked at $8.33M in Q3 2024. 1,403 funds tracked by Wall St. Rank hold APH as of Q4 2024.

BSN Capital Partners reported no remaining Amphenol position as of Q4 2024 after selling out during the quarter.
BSN Capital Partners sold 119,458 Amphenol shares in Q4 2024, an estimated $8.33M.
BSN Capital Partners first reported a position in Amphenol in Q3 2024 and held it in 1 quarter.
BSN Capital Partners's Amphenol position peaked at $8.33M in Q3 2024.
1,403 funds tracked by Wall St. Rank held Amphenol as of Q4 2024.

Based on BSN Capital Partners's 13F filing for Q4 2024, filed 28 Jan 2025.